Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Kumaraguru Raja's Stock Ratings
Brookline Capital Analyst
Kumaraguru Raja is an analyst at Brookline Capital. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/23/2025
Overall Average Return
-51.6%
Smart Score
Overall Average Return Percentile
3rd
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 05/13/2025 | PALI | Buy Now | Palisade Bio | $0.72 | 2122.22% | Kumaraguru Raja20% | $16 → $16 | Maintains | Buy | Get Alert |
| 12/18/2024 | QNCX | Buy Now | Quince Therapeutics | $1.32 | 581.82% | Kumaraguru Raja20% | → $9 | Initiates | → Buy | Get Alert |
| 11/20/2024 | PALI | Buy Now | Palisade Bio | $0.72 | 5177.78% | Kumaraguru Raja20% | → $38 | Initiates | → Buy | Get Alert |
| 06/07/2024 | SABS | Buy Now | SAB Biotherapeutics | $1.81 | 341.99% | Kumaraguru Raja20% | → $8 | Initiates | → Buy | Get Alert |
| 05/30/2024 | FBRX | Buy Now | Forte Biosciences | $12.94 | -69.08% | Kumaraguru Raja20% | → $4 | Initiates | → Buy | Get Alert |
| 12/07/2023 | HEPA | Buy Now | Hepion Pharmaceuticals | $0.07 | — | Kumaraguru Raja20% | — | Downgrade | Buy → Hold | Get Alert |
| 08/30/2023 | OTLK | Buy Now | Outlook Therapeutics | $1.71 | — | Kumaraguru Raja20% | — | Downgrade | Buy → Hold | Get Alert |
| 07/11/2023 | ADIL | Buy Now | Adial Pharmaceuticals | $0.26 | 2181.46% | Kumaraguru Raja20% | → $6 | Reiterates | Buy → Buy | Get Alert |
| 06/29/2023 | GNTA | Buy Now | Genenta Science | $3.09 | 385.44% | Kumaraguru Raja20% | → $15 | Assumes | → Buy | Get Alert |
| 03/06/2023 | LIFE | Buy Now | aTyr Pharma | — | — | Kumaraguru Raja20% | → $9 | Reinstates | → Buy | Get Alert |
| 01/31/2023 | RAIN | Buy Now | Rain Oncology | $2.97 | 607.07% | Kumaraguru Raja20% | → $21 | Reinstates | → Buy | Get Alert |
| 01/24/2023 | APGN | Buy Now | Apexigen | — | — | Kumaraguru Raja20% | → $15 | Reinstates | → Buy | Get Alert |
| 12/09/2022 | MNPR | Buy Now | Monopar Therapeutics | $32.29 | -44.26% | Kumaraguru Raja20% | → $18 | Reinstates | → Buy | Get Alert |
| 05/18/2022 | VERU | Buy Now | Veru | $0.61 | 4954.62% | Kumaraguru Raja20% | $29 → $31 | Maintains | Buy | Get Alert |
| 10/13/2021 | ADIL | Buy Now | Adial Pharmaceuticals | $0.26 | 4462.91% | Kumaraguru Raja20% | → $12 | Initiates | → Buy | Get Alert |
| 09/21/2021 | DRMA | Buy Now | Dermata Therapeutics | $0.64 | 2087.5% | Kumaraguru Raja20% | → $14 | Initiates | → Buy | Get Alert |
| 09/03/2021 | FBRX | Buy Now | Forte Biosciences | $12.94 | — | Kumaraguru Raja20% | — | Downgrade | Buy → Hold | Get Alert |
| 03/30/2021 | ONCT | Buy Now | Oncternal Therapeutics | — | — | Kumaraguru Raja20% | → $16 | Initiates | → Buy | Get Alert |
| 03/25/2021 | NMTR | Buy Now | 9 Meters Biopharma | — | — | Kumaraguru Raja20% | → $6 | Assumes | → Buy | Get Alert |
| 07/30/2019 | VERU | Buy Now | Veru | $0.61 | 1856.63% | Kumaraguru Raja20% | → $12 | Initiates | → Buy | Get Alert |
